How pharma marketing can stay ahead of the evolving customer journeyOverview Customer journeys in pharma are changing, with important implications for the marketing supply chain. How can pharmaceutical Share XHow pharma marketing can stay ahead of the evolving customer journeyhttps://pharmaphorum.com/digital/how-pharma-marketing-can-stay-ahead-of-the-evolving-customer-journey/
CVS Health funds insomnia app, stop smoking support could followThe influential US pharmacy benefit manager CVS Health has said it will fund an insomnia app, allowing it Share XCVS Health funds insomnia app, stop smoking support could followhttps://pharmaphorum.com/news/cvs-health-funds-insomnia-app-stop-smoking-and-abuse-support-could-follow/
Scientists recreate blood-brain barrier on a chipScientists in Israel and the US have duplicated the blood-brain barrier in a chip using human stem cells, Share XScientists recreate blood-brain barrier on a chiphttps://pharmaphorum.com/news/scientists-recreate-blood-brain-barrier-on-a-chip/
Exscientia begins China AI drug discovery tie-up with GT ApeironUK Artificial Intelligence (AI) drug discovery firm Exscientia has begun a collaboration with China’s GT Apeiron Therapeutics, focusing Share XExscientia begins China AI drug discovery tie-up with GT Apeironhttps://pharmaphorum.com/news/exscientia-begins-china-ai-drug-discovery-tie-up-with-gt-apeiron/
Reimagining commercialisation with AIWe speak to Indegene’s Gaurav Kapoor to find out how he thinks pharma’s sales and marketing model needs Share XReimagining commercialisation with AIhttps://pharmaphorum.com/views-analysis-digital/reimagining-commercialisation-with-ai/
Many patients don’t have, or are unaware of e-health records, says reportNetherlands-based health technology firm Royal Philips has published its fourth global report exploring the impact of digital health Share XMany patients don’t have, or are unaware of e-health records, says reporthttps://pharmaphorum.com/news/many-patients-dont-have-or-unaware-of-e-health-records-says-report/
NHS England gets commercialNHS England is no longer the new kid on the block, taking up its role in 2013. In Share XNHS England gets commercialhttps://deep-dive.pharmaphorum.com/magazine/access-and-commercialisation/nhs-england-commercial-framework-vpas/
Under the skin of innovationLEO’s Innovation Lab is working at arm’s length from the main company to encourage original thinking and develop Share XUnder the skin of innovationhttps://deep-dive.pharmaphorum.com/magazine/access-and-commercialisation/leo-innovation-lab-john-zibert-digital/
UK public concerned about tech firms profiting from NHS dataOnly a small proportion of the UK public trusts tech multinationals with sensitive health data, although a survey Share XUK public concerned about tech firms profiting from NHS datahttps://pharmaphorum.com/news/uk-public-concerned-about-tech-firms-profiting-from-nhs-data/
